Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (1091-1100 of 1,161) with videos related to

Pageof 117
Sort By:
Biorxiv : the Preprint Server for Biology|October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesisVera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder CancerGopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.
Journal of the National Cancer Institute|March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic NeoplasmsMaeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Leukemia|December 16, 2006
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936P A S Evans, Ch Pott, P J T A Groenen, et al.
Nature Biotechnology|November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer typesDiego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Cancer Discovery|November 10, 2022
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal CancerRona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Therapeutic Implications of Germline Testing in Patients With Advanced CancersZsofia K Stadler, Anna Maio, Debyani Chakravarty, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Pageof 117

Showing results (1091-1100 of 1,161) with videos related to

Sort By:
Pageof 117
Biorxiv : the Preprint Server for Biology|October 17, 2024
Targetable treatment resistance in thyroid cancer with clonal hematopoiesisVera Tiedje, Pablo Sánchez Vela, Julie L Yang, et al.
Nature|December 12, 2019
Author Correction: Tumour lineage shapes BRCA-mediated phenotypesPhilip Jonsson, Chaitanya Bandlamudi, Michael L Cheng, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2018
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder CancerGopa Iyer, Arjun V Balar, Matthew I Milowsky, et al.
Journal of the National Cancer Institute|March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic NeoplasmsMaeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Leukemia|December 16, 2006
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936P A S Evans, Ch Pott, P J T A Groenen, et al.
Nature Biotechnology|November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer typesDiego Chowell, Seong-Keun Yoo, Cristina Valero, et al.
Cancer Discovery|November 10, 2022
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal CancerRona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2021
Therapeutic Implications of Germline Testing in Patients With Advanced CancersZsofia K Stadler, Anna Maio, Debyani Chakravarty, et al.
Nature Cancer|September 1, 2020
Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitorsPedram Razavi, Maura N Dickler, Payal D Shah, et al.
Pageof 117